Literature DB >> 28910194

Chikungunya Virus-Induced Arthritis: Role of Host and Viral Factors in the Pathogenesis.

Sarika Amdekar1, Deepti Parashar1, Kalichamy Alagarasu1.   

Abstract

Chikungunya virus (CHIKV), a member of Alphavirus genus, is responsible for chikungunya fever (CHIKF), which is characterized by the presence of fever, rash, myalgia, and arthralgia. Reemergence of CHIKV has become a significant public health concern in Asian and African countries and is newly emerging in the Middle East, Pacific, American, and European countries. Cytokines, innate (monocytes, natural killer cells) and adaptive immune response (role of B cells and T cells i.e. CD4+ and CD8+), and/or viral factors contribute to CHIKV-induced arthritis. Vector factors such as vector competence (that includes extrinsic and intrinsic factors) and effect of genome mutations on viral replication and fitness in mosquitoes are responsible for the spread of virus, although they are not directly responsible for CHIKV-induced arthritis. CHIKV-induced arthritis mimics arthritis by involving joints and a common pattern of leukocyte infiltrate, cytokine production, and complement activation. Successful establishment of CHIKV infection and induction of arthritis depends on its ability to manipulate host cellular processes or host factors. CHIKV-induced joint damage is due to host inflammatory response mediated by macrophages, T cells, and antibodies, as well as the possible persistence of the virus in hidden sites. This review provides insight into mechanisms of CHIKV-induced arthritis. Understanding the pathogenesis of CHIKV-induced arthritis will help in developing novel strategies to predict and prevent the disease in virus-infected subjects and combat the disease, thereby decreasing the worldwide burden of the disease.

Entities:  

Keywords:  arthritis; chikungunya virus; cytokines; immune response; joint pain; nonsteroidal anti-inflammatory drugs (NSAIDs)

Mesh:

Substances:

Year:  2017        PMID: 28910194     DOI: 10.1089/vim.2017.0052

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  8 in total

1.  A potent prolyl tRNA synthetase inhibitor antagonizes Chikungunya and Dengue viruses.

Authors:  Jesse Hwang; Alfred Jiang; Erol Fikrig
Journal:  Antiviral Res       Date:  2018-12-03       Impact factor: 5.970

2.  Antibody response patterns in chikungunya febrile phase predict protection versus progression to chronic arthritis.

Authors:  Kaustuv Nayak; Vineet Jain; Manpreet Kaur; Naushad Khan; Kamalvishnu Gottimukkala; Charu Aggarwal; Rohit Sagar; Shipra Gupta; Ramesh Chandra Rai; Kritika Dixit; Mohammad Islamuddin; Wajihul Hasan Khan; Anil Verma; Deepti Maheshwari; Yadya M Chawla; Elluri Seetharami Reddy; Harekrushna Panda; Pragati Sharma; Priya Bhatnagar; Prabhat Singh; Siva Raghavendhar B; Ashok Kumar Patel; Vinod H Ratageri; Anmol Chandele; Pratima Ray; Kaja Murali-Krishna
Journal:  JCI Insight       Date:  2020-04-09

3.  Whole Transcriptome Analysis of Aedes albopictus Mosquito Head and Thorax Post-Chikungunya Virus Infection.

Authors:  Ravi Kiran Vedururu; Matthew J Neave; Vinod Sundaramoorthy; Diane Green; Jennifer A Harper; Paul R Gorry; Jean-Bernard Duchemin; Prasad N Paradkar
Journal:  Pathogens       Date:  2019-08-27

Review 4.  Cellular and Molecular Immune Response to Chikungunya Virus Infection.

Authors:  Ithallo S B Tanabe; Eloiza L L Tanabe; Elane C Santos; Wanessa V Martins; Isadora M T C Araújo; Maria C A Cavalcante; Ana R V Lima; Niels O S Câmara; Leticia Anderson; Dinar Yunusov; Ênio J Bassi
Journal:  Front Cell Infect Microbiol       Date:  2018-10-10       Impact factor: 5.293

Review 5.  Disease Resolution in Chikungunya-What Decides the Outcome?

Authors:  Priyanshu Srivastava; Ankit Kumar; Abdul Hasan; Divya Mehta; Ramesh Kumar; Chetan Sharma; Sujatha Sunil
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

6.  Neutrophil Extracellular Traps Effectively Control Acute Chikungunya Virus Infection.

Authors:  Carlos H Hiroki; Juliana E Toller-Kawahisa; Marcilio J Fumagalli; David F Colon; Luiz T M Figueiredo; Bendito A L D Fonseca; Rafael F O Franca; Fernando Q Cunha
Journal:  Front Immunol       Date:  2020-01-31       Impact factor: 7.561

7.  In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro disease.

Authors:  Mânlio Tasso de Oliveira Mota; Vivian Vasconcelos Costa; Michelle Amantéa Sugimoto; Georgia de Freitas Guimarães; Celso Martins Queiroz-Junior; Thaiane Pinto Moreira; Carla Daiane de Sousa; Franciele Martins Santos; Victoria Fulgêncio Queiroz; Ingredy Passos; Josy Hubner; Danielle Gloria Souza; Scott C Weaver; Mauro Martins Teixeira; Maurício Lacerda Nogueira
Journal:  Sci Rep       Date:  2020-03-24       Impact factor: 4.379

8.  Mosquito-bite infection of humanized mice with chikungunya virus produces systemic disease with long-term effects.

Authors:  Brianne M Hibl; Natalie J M Dailey Garnes; Alexander R Kneubehl; Megan B Vogt; Jennifer L Spencer Clinton; Rebecca R Rico-Hesse
Journal:  PLoS Negl Trop Dis       Date:  2021-06-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.